Press and Announcements
Regenerative medicine is a rapidly advancing area of medine providing the some of the most significant as it delivers Cellular Tissue Products, stimulating the body’s natural healing process by activating the body’s own ability to repair and regenerate. Innovative therapies are available that aid in healing or reconstruct damaged tissue and support the regeneration of injured cells and organs. As press announcements become available on the company, the market or new products Olaregen will post announcements below to keep you current on these very important topics.
Current Events - Press Releases - News and Science Information you shouldn't miss.
10/10/2019
Generex Biotechnology Announces that Excellagen® Inventor, Dr. Lois Chandler will Present Clinical Data on Rapid Healing of Diabetic Foot Ulcers at The Symposium on Advanced Wound Care (SAWC) Fall Meeting
10/01/2019
Generex Biotechnology Corporation (GNBT), is pleased to announce that their subsidiary, Olaregen Therapeutix, Inc. today officially launched the Excellagen 3.0 cc pre-filled syringe.
09/30/2019
Generex Biotechnology Subsidiary Olaregen Therapeutix Signs National Sales & Distribution Agreement With AvKare Medical to Distribute Excellagen® Throughout the VA Hospital System
07/15/2019
Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors APMA Annual Scientific Meeting
07/12/2019
Generex Biotechnology Announces Closing on Acquisition of MediSource Partners
07/10/2019
Generex Biotechnology Provides Fiscal Year Overview
06/26/2019
Generex Biotechnology Subsidiary Olaregen Therapeutix Receives American Podiatry Medical Associations “Seal of Approval” for Excellagen® Wound Conforming Matrix
Generex Biotechnology Announces that its Subsidiary Olaregen Therapeutix Launches Excellagen® at The Symposium on Advanced Wound Care (SAWC) in San Antonio, TX
Olaregen Therapeutix Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage Meeting..
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Appointment of Vice President of Business Strategy
Generex Biotechnology Subsidiary Olaregen Therapeutix Inc. Plans Launch of FDA Cleared…
Generex Biotechnology Completes Acquisition of Olaregen Therapeutix Inc.
Generex Biotechnology Partner Olaregen Therapeutix Inc. Signs Manufacturing Agreements for…
Generex Biotechnology Partner Olaregen Therapeutix Inc. Establishes Sales Force and Distribution Team for
Generex Biotechnology Partner Olaregen Therapeutix Sponsors Annual Meeting of Innovations in Wound…
Generex Biotechnology Adds World-Class Leadership to Executive Management Team
Generex Biotechnology Expands Medical Device Portfolio with Acquisition of Olaregen Therapeutix Inc